FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
02 déc. 2019 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, Dec. 02, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported roxadustat has been included on the updated National Reimbursement Drug List (NRDL) released by China’s...